Literature DB >> 36271021

Different timing and risk factors of cause-specific pancreas graft loss after simultaneous pancreas kidney transplantation.

Yoshito Tomimaru1,2, Shogo Kobayashi3, Toshinori Ito2,4, Kazuki Sasaki1, Yoshifumi Iwagami1, Daisaku Yamada1, Takehiro Noda1, Hidenori Takahashi1, Takashi Kenmochi2,5, Yuichiro Doki1, Hidetoshi Eguchi1.   

Abstract

In cases after pancreas transplantation (PTx), the pancreas graft might be lost for various reasons, including a pancreatoduodenal graft-related complication or patient death with a functioning graft. Although the causes seem to have distinct characteristics, the causes of pancreas graft loss have not been characterized. This study aimed to characterize the causes of pancreas graft loss by analyzing data from a Japanese nationwide registry. This study included 391 patients who received simultaneous pancreas-kidney transplantation among 461 patients with PTx during the study period in approved institutions in Japan. We characterized each cause in terms of the timing of the cause-specific graft loss and preoperative factors associated with graft loss based on nationwide data from a Japanese nationwide registry. Among the 391 cases, 113 lost the pancreas graft due to patient death with a functioning graft (DWFG; n = 34, 44.2%), graft thrombus (n = 22, 28.6%), or chronic rejection (CR; n = 7, 9.1%). Average (± standard deviation) time from PTx to graft loss due to DWFG, graft thrombus, and CR was 3.70 ± 4.36, 0.02 ± 0.01, and 2.37 ± 2.08 years, respectively. Duration of type 1 diabetes mellitus and donor body mass index were significantly associated with pancreas graft loss due to DWFG and graft thrombus, respectively. This characterization showed that the timing and preoperative factors associated with pancreas graft loss were significantly different for different causes of graft loss. These results may inform PTx follow-up protocols to ensure that appropriate care is based on the cause of graft loss.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36271021     DOI: 10.1038/s41598-022-22321-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  25 in total

1.  Strategies to expand the donor pool for pancreas transplantation.

Authors:  S Kapur; C A Bonham; S F Dodson; I Dvorchik; R J Corry
Journal:  Transplantation       Date:  1999-01-27       Impact factor: 4.939

Review 2.  Pancreas transplantation.

Authors:  Steve A White; James A Shaw; David E R Sutherland
Journal:  Lancet       Date:  2009-05-23       Impact factor: 79.321

3.  Outcomes of simultaneous pancreas and kidney transplants based on preemptive transplant compared to those who were on dialysis before transplant - a retrospective study.

Authors:  Sandesh Parajuli; Kurtis J Swanson; Ravi Patel; Brad C Astor; Fahad Aziz; Neetika Garg; Maha Mohamed; Talal Al-Qaoud; Robert Redfield; Arjang Djamali; Dixon Kaufman; Jon Odorico; Didier A Mandelbrot
Journal:  Transpl Int       Date:  2020-06-18       Impact factor: 3.782

4.  Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy.

Authors:  W D Kelly; R C Lillehei; F K Merkel; Y Idezuki; F C Goetz
Journal:  Surgery       Date:  1967-06       Impact factor: 3.982

5.  Pancreas Transplantation of US and Non-US Cases from 2005 to 2014 as Reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).

Authors:  Angelika C Gruessner; Rainer W G Gruessner
Journal:  Rev Diabet Stud       Date:  2016-03-14

Review 6.  Pancreas transplantation in the United States: a review.

Authors:  Angelika C Gruessner; David E R Sutherland; Rainer W G Gruessner
Journal:  Curr Opin Organ Transplant       Date:  2010-02       Impact factor: 2.640

Review 7.  Kidney and pancreas transplantation in type 1 diabetes mellitus.

Authors:  Susan M Lerner
Journal:  Mt Sinai J Med       Date:  2008-08

Review 8.  Simultaneous pancreas-kidney transplantation: The role in the treatment of type 1 diabetes and end-stage renal disease.

Authors:  Alex T Jiang; Neal Rowe; Alp Sener; Patrick Luke
Journal:  Can Urol Assoc J       Date:  2014-03       Impact factor: 1.862

9.  A New Modified Experimental Meibomian Gland Injury Model: Partial Loss of Gland Due to Orifice Cauterization and the Alleviating Potential of 22-Oxacalcitriol.

Authors:  Kai Jin; Motoko Kawashima; Masataka Ito; Reiko Arita; Kokoro Sano; Kazuo Tsubota
Journal:  J Clin Med       Date:  2020-12-22       Impact factor: 4.241

Review 10.  Current state of pancreas transplantation in Japan based on the nationwide registry.

Authors:  Yoshito Tomimaru; Hidetoshi Eguchi; Yuichiro Doki; Toshinori Ito; Takashi Kenmochi
Journal:  Ann Gastroenterol Surg       Date:  2021-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.